Detalhe da pesquisa
1.
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
N Engl J Med
; 389(2): 137-147, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272535
2.
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
Lancet Oncol
; 20(12): 1670-1680, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601496
3.
Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
Target Oncol
; 19(2): 131-134, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38466534
4.
Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients.
BMC Nephrol
; 14: 40, 2013 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23418668
5.
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study.
J Clin Oncol
; 41(6): 1213-1227, 2023 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327426
6.
Results of a pilot program to improve phosphorus outcomes in hemodialysis patients.
J Ren Nutr
; 22(5): 472-9, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22056148
7.
Lanthanum carbonate reduces urine phosphorus excretion: evidence of high-capacity phosphate binding.
Ren Fail
; 34(3): 263-70, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22250993
8.
Comparison of dietary phosphate absorption after single doses of lanthanum carbonate and sevelamer carbonate in healthy volunteers: a balance study.
Am J Kidney Dis
; 57(5): 700-6, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21354682
9.
The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol.
Nephrol Dial Transplant
; 26(5): 1615-21, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20921291
10.
Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study.
Lung Cancer
; 147: 137-142, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702570
11.
Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naïve Swedish children and adolescents.
Eur Child Adolesc Psychiatry
; 18(4): 240-9, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19156355
12.
The provision and nature of ADHD services for children/adolescents in the UK: results from a nationwide survey.
Clin Child Psychol Psychiatry
; 13(2): 287-304, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18540230
13.
Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: The Disability in Strategies for Care (DISC) Study.
Pharmacoeconomics
; 20(2): 91-100, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-11888361
14.
Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients.
Int J Nephrol Renovasc Dis
; 7: 261-9, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25045277
15.
Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
Eur Neuropsychopharmacol
; 19(11): 822-34, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19716683
16.
A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD).
Curr Med Res Opin
; 23(2): 379-94, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17288692
17.
Cross-cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European study.
Eur Child Adolesc Psychiatry
; 15 Suppl 1: I46-55, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17177016